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Genetic circuits can now be engineered that perform
moderately complicated switching functions or exhibit
predictable dynamical behavior. These ‘forward
engineering’ techniques may have to be combined with
directed evolution techniques to produce robustness
comparable with naturally occurring circuits.
Addresses: *Department of Developmental Biology, School of
Medicine, Stanford University, Stanford, California 94305, USA.
†Departments of Bioengineering and Chemistry, University of California
and Physical Biosciences Division, E.O. Lawrence Berkeley National
Laboratory, Berkeley, California 94720, USA.
E-mail: mcadams@cmgm.stanford.edu
aparkin@lbl.gov
Current Biology 2000, 10:R318–R320
0960-9822/00/$ – see front matter 
© 2000 Elsevier Science Ltd. All rights reserved.
In a summary of the general conclusions of a 1961 Cold
Spring Harbor Symposium, Monod and Jacob comment
that “it is obvious from the analysis of these [bacterial
genetic regulatory] mechanisms that their known elements
could be connected into a wide variety of ‘circuits’ endowed
with any desired degree of stability” [1]. It is remarkable
that now, nearly 40 years later, with near universal accep-
tance of the validity of Monod and Jacob’s vision, the prac-
tice of genetic circuit engineering is still in its infancy. Two
papers published recently in Nature [2,3] provide a snapshot
of the current state of the discipline. Elowitz and
Leibler [2] describe a genetic circuit engineered into
Escherichia coli cells that oscillates asynchronously with
regard to the cell-division cycle. Gardner et al. [3] describe a
toggle-switch circuit that can be switched between two
stable states by transient external signals. In both studies,
the circuits’ qualitative performance is consistent with the
predictions of relatively simple differential equation models
that characterize the dynamics of production, degradation
and genetic regulation. 
The central feature of the toggle switch is a bistable, two-
promoter configuration, involving constitutively active
and repressible promoters (Figure 1a, P1 and P2), that
each control transcription of a repressor of the other when
activated. It is intuitively clear that there are likely to be
two stable situations, P1 ON or P2 ON, given comparable
promoter kinetics. Gardner et al. [3] demonstrate how this
inherently bistable configuration can be engineered so
that external signals can flip the system from one state to
the other. In one design, for example, P2 is an IPTG-
inducible lac promoter, R1 is a thermally unstable CI
repressor, and the state of the switch is sensed by addi-
tion of a reporter gene coding for green fluorescent
protein (GFP) directly downstream of the cI gene
(Figure 1b). Gardner et al. [3] found that all cells in
colonies grown for six hours in the presence of IPTG
under conditions for CI stability remained in the P2 ON
state after removal of the IPTG signal. Transiently raising
the temperature so that CI was unstable for seven hours
caused the cell population to switch completely to the
alternative P1 ON state. 
Sophisticated engineering of artificial genetic switches is
not at all new [4], but this is perhaps the first engineered
design that exploits bistability to produce a switch with the
capability of reversibly switching between two alternative
stable expression states. One can envision variations in the
design where, say, IPTG is replaced by a signal transmit-
ted by a ‘two-component’ system — a kind of signal trans-
duction mechanism commonly found in bacteria consisting
of transmembrane receptor and response-regulator compo-
nents — so that the cells would continuously express the
GFP after one extended encounter with the receptor’s
activating ligand. Or genes for two alternative regulon-con-
trolling proteins could be inserted downstream to the
genes for R1 and R2, enabling toggling between alternative
metabolic or morphological states.
Figure 1
(a) Inherently bistable configuration of mutually
antagonistic repressors. (b) One of two
genetic toggle switch designs based on this
bistable switch concept implemented in [3].
Exposure to IPTG switches the cell
population to the Plac ON state. In the
absence of IPTG, exposure to the
temperature range of CI instability toggles the
switch to the PL ON state. The asterisk
indicates that the CI used in this genetic
switch is thermally unstable.
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The synthetic oscillator circuit described by Elowitz and
Leibler [2] has less immediately evident technical
applications. What possible use is there for a bacterial
population engineered to glow intermittently and
erratically like a crowd of drunken fireflies? Well, probably
not much. But pursuing the effort to design an artificial
oscillator with a robust, predictable frequency that is
reliably inherited at cell division could lead to deep
insights into the design rules underlying natural oscillatory
systems. Furthermore, resolving differences between the
behavior predicted from quantitative simulation and the
experimentally observed behavior should greatly improve
our understanding of the intracellular environment.
The design of the oscillatory circuit, referred to as a ‘repres-
silator’, involves a daisy-chain of promoter–repressor pairs
(Figure 2a), producing a cyclic negative feedback loop,
engineered onto a low copy number plasmid. Elowitz and
Leibler [2] modeled the configuration’s protein production
and degradation dynamics using a system of coupled differ-
ential equations, and identified molecular characteristics of
the components favoring limit-cycle oscillations (a limit-
cycle oscillator undergoes periodic transitions between two
alternative extreme states of the system). Following design
insights from the model, the circuit was constructed with
relatively strong promoters and with repressor molecules
engineered for short half-lives. Oscillations were monitored
by a separate, higher copy plasmid containing a TetR-
repressible promoter fused to the gene for a short-lived
GFP. Some 40% of the cells containing the oscillator and
monitor plasmids exhibited oscillatory behavior. Simula-
tions of the predicted circuit behavior, using stochastic
kinetics for the genetic mechanisms of transcription and
translation, predicted highly variable oscillations, and the
observed oscillations were indeed quite erratic.
Stochastic phenomena undoubtedly are the cause of the
failure of oscillations in 60% of the cells and for the erratic
changes in behavior observed in the oscillatory 40% at cell
septation times. The repressilator design has additional
sources of stochastic variation beyond stochastic gene
expression kinetics. For example, the number of plasmids
containing the oscillator circuit and the number of plasmids
containing the GFP reporter construct will each vary inde-
pendently from cell to cell; there will be random variations
in the partitioning of both the plasmids and the repressor
protein populations at the time of septation; and the GFP
protein folding times will also exhibit statistical variation. 
While cells have solved the problem of construction of
robust and predictable circuits from inherently noisy com-
ponents, there is currently only limited understanding of
how these natural circuits are designed to achieve stability
and predictability. In a related paper in the same journal
issue, Barkai and Leibler [5] model a different hypotheti-
cal oscillator circuit design, shown in Figure 2b. Their
modeling results suggest that this design would have
stable oscillations and be relatively insensitive to global
changes in the cell. It will be interesting indeed to see if
cells containing a circuit of this design actually exhibit the
predicted increased stability. Rational circuit designs for
many applications, therapeutic applications for example,
will have to have qualities of robustness and reliability
comparable to natural circuits. As we do not yet know the
design principles of natural circuits, this presents a consid-
erable challenge for design de novo. The many frustrations
of metabolic engineers seeking to reengineer metabolic
pathways for novel functions illustrate this problem.
Traditionally, the engineering of cellular circuitry has
been an industrial practice. The most developed aspect of
this field is in metabolic engineering [6–9]. Metabolic
engineering generally involves the modification of cells,
usually bacteria, to overproduce endogenous or heterolo-
gous natural products. Two approaches have been taken
to this challenge: first, ‘rational analysis’ to determine
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Figure 2
(a) With suitable choices of component kinetics and favorable gene
dosage conditions, this circular genetic cascade of three
repressor–promoter links creates an oscillator circuit termed a
‘repressilator’ [2]. In this specific case, the repressors are as follows: R1,
LacI; R2, CI; R3, TatR. (b) A genetic circuit predicted to exhibit relatively
robust hysteresis-based oscillations [5]. Protein R, when present, binds
strongly to A, so that P2 is no longer activated. Resulting alternating
periods of R production and degradation create the oscillatory behavior.
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changes to engineer into the pathways; and second,
‘directed evolution’ to produce strain improvement by
selective pressure (for example [9]). Rational analysis tech-
niques include metabolic control and flux analysis, thermo-
dynamic analysis and full kinetic modeling [10–12]. The
goal is usually to maximize output of a valuable product, to
minimize feedstock costs, or to increase reliability. The
complexity of the cellular environment is a limiting factor
in the rational design approach, so that additional selec-
tion-driven evolution is almost always necessary [13]. 
It does seem that ambitions for the size, complexity and
type of circuit and pathway changes have outstripped our
ability to predict their behavior quantitatively, and
perhaps even our ability to select for the required behav-
ior. It will be a challenge, for example, to design selection
schemes that can be used to drive cells containing artifi-
cially engineered oscillator circuits toward robust, reliable,
noise-resistant oscillation by successive selections. The
emerging paradigm for genetic circuit engineering is to
use relatively accurate simulation techniques to design
cellular circuits that operate within a ‘selection distance’
of target specifications. The engineered cells containing
circuits that are in weak compliance with the desired spec-
ification will then have an enhanced probability of produc-
ing more compliant mutants that can be captured in a
‘directed evolution’ selection screen.
What types of engineered circuits will be useful? Engi-
neering tasks that are central now include the following
examples: the design of pathways for production of indus-
trial or medically important molecules such as detergent
proteins or antibiotics; the design of cells and viruses that
perform complex tasks, such as multistep degradations
and conversions in bioremediation or cell-specific activity
for gene therapy; and the design of circuits to probe the
cellular environment or to aid in molecular biological
research. In the near term, we can expect a variety of rela-
tively simple, but useful, types of cellular switches, trans-
ducers, signal processors, sensors and actuators built out of
more or less standard parts. 
The engineering challenge is to design for reliable
performance over a wide range of time-scales and under a
wide range of environmental conditions. Undoubtedly,
this will require moving beyond circuits solely consisting
of genetic elements to circuit designs incorporating
engineered protein–protein or protein–metabolite interac-
tions to achieve the speed necessary for certain functions.
Surely genetic circuit engineering will emulate the older
engineering disciplines and progress to production of well-
characterized components with good quality control and
the capability to accurately predict the behavior of pro-
posed circuits with future bioengineering computer-aided
design tools. The ability to rationally engineer a system is
perhaps the most stringent indicator of understanding. By
that criterion, it seems we are still near the very beginning
of a long and fruitful scientific and engineering journey.
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